These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38588650)

  • 21. Will urinary biomarkers provide a breakthrough in diagnosing cardiac surgery-associated AKI? - A systematic review.
    Hussain ML; Hamid PF; Chakane N
    Biomarkers; 2020 Jul; 25(5):375-383. PubMed ID: 32479185
    [No Abstract]   [Full Text] [Related]  

  • 22. Tissue Inhibitor Metalloproteinase-2 (TIMP-2)⋅IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI.
    Koyner JL; Shaw AD; Chawla LS; Hoste EA; Bihorac A; Kashani K; Haase M; Shi J; Kellum JA;
    J Am Soc Nephrol; 2015 Jul; 26(7):1747-54. PubMed ID: 25535301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary [TIMP-2] × [IGFBP7] for risk prediction of acute kidney injury in decompensated heart failure.
    Schanz M; Shi J; Wasser C; Alscher MD; Kimmel M
    Clin Cardiol; 2017 Jul; 40(7):485-491. PubMed ID: 28295429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of cardiac surgery-associated acute kidney injury from functional to damage biomarkers.
    Vandenberghe W; De Loor J; Hoste EA
    Curr Opin Anaesthesiol; 2017 Feb; 30(1):66-75. PubMed ID: 27906719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of acute kidney injury by urinary tissue inhibitor metalloproteinases-2 and insulin-like growth factor-binding protein 7 after pediatric cardiac surgery.
    Tao Y; Heskia F; Zhang M; Qin R; Kang B; Chen L; Wu F; Huang J; Brengel-Pesce K; Chen H; Mo X; Liang J; Wang W; Xu Z
    Pediatr Nephrol; 2022 Nov; 37(11):2743-2753. PubMed ID: 35211796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of TIMP-2 and IGFBP-7 for prediction of postoperative acute kidney injury after cardiac surgery.
    Yu PJ; Rodriguez G; Cassiere H; Bocchieri K; Hirsch JS; Chang TY; Jhaveri KD; Hentz R; Fishbane S; Sharma PD; Delijani D; Hartman A
    Clin Nephrol; 2022 Dec; 98(6):288-295. PubMed ID: 36331021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.
    Toprak Z; Cebeci E; Helvaci SA; Toprak ID; Kutlu Y; Sakin A; Tukek T
    Int Urol Nephrol; 2017 Jun; 49(6):1041-1047. PubMed ID: 28255639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication.
    Bihorac A; Chawla LS; Shaw AD; Al-Khafaji A; Davison DL; Demuth GE; Fitzgerald R; Gong MN; Graham DD; Gunnerson K; Heung M; Jortani S; Kleerup E; Koyner JL; Krell K; Letourneau J; Lissauer M; Miner J; Nguyen HB; Ortega LM; Self WH; Sellman R; Shi J; Straseski J; Szalados JE; Wilber ST; Walker MG; Wilson J; Wunderink R; Zimmerman J; Kellum JA
    Am J Respir Crit Care Med; 2014 Apr; 189(8):932-9. PubMed ID: 24559465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical Illness.
    McCullough PA; Ostermann M; Forni LG; Bihorac A; Koyner JL; Chawla LS; Shi J; Kampf JP; McPherson P; Kellum JA;
    Cardiorenal Med; 2019; 9(6):358-369. PubMed ID: 31618746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interest of Urinary [TIMP-2] × [IGFBP-7] for Predicting the Occurrence of Acute Kidney Injury After Cardiac Surgery: A Gray Zone Approach.
    Finge T; Bertran S; Roger C; Candela D; Pereira B; Scott C; Muller L; Louart B; Lefrant JY
    Anesth Analg; 2017 Sep; 125(3):762-769. PubMed ID: 28537976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TIMP-2/IGFBP7 predicts acute kidney injury in out-of-hospital cardiac arrest survivors.
    Adler C; Heller T; Schregel F; Hagmann H; Hellmich M; Adler J; Reuter H
    Crit Care; 2018 May; 22(1):126. PubMed ID: 29751827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk prediction of acute kidney injury by [TIMP-2]•[IGFBP7].
    Kimmel M; Schanz M; Alscher MD
    Drugs Today (Barc); 2017 Jun; 53(6):349-356. PubMed ID: 28799580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of cell-cycle arrest biomarkers for acute kidney injury after pediatric cardiac surgery.
    Meersch M; Schmidt C; Van Aken H; Rossaint J; Görlich D; Stege D; Malec E; Januszewska K; Zarbock A
    PLoS One; 2014; 9(10):e110865. PubMed ID: 25343505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effectiveness of urinary TIMP-2 and IGFBP-7 in predicting acute kidney injury in critically ill neonates.
    Chen J; Sun Y; Wang S; Dai X; Huang H; Bai Z; Li X; Wang J; Li Y
    Pediatr Res; 2020 May; 87(6):1052-1059. PubMed ID: 31791043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TIMP2•IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients.
    Gunnerson KJ; Shaw AD; Chawla LS; Bihorac A; Al-Khafaji A; Kashani K; Lissauer M; Shi J; Walker MG; Kellum JA;
    J Trauma Acute Care Surg; 2016 Feb; 80(2):243-9. PubMed ID: 26816218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urine cell cycle arrest biomarkers distinguish poorly between transient and persistent AKI in early septic shock: a prospective, multicenter study.
    Titeca-Beauport D; Daubin D; Van Vong L; Belliard G; Bruel C; Alaya S; Chaoui K; Andrieu M; Rouquette-Vincenti I; Godde F; Pascal M; Diouf M; Vinsonneau C; Klouche K; Maizel J
    Crit Care; 2020 Jun; 24(1):280. PubMed ID: 32487237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early recognition of cardiac surgery-associated acute kidney injury: lack of added value of TIMP2 IGFBP7 over short-term changes in creatinine (an observational pilot study).
    Lakhal K; Bigot-Corbel E; Sacchetto E; Chabrun F; Senage T; Figueres L; Leroy M; Legrand A; Rozec B
    BMC Anesthesiol; 2021 Oct; 21(1):244. PubMed ID: 34641779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Cell Cycle Arrest Biomarkers in Conjunction With Classical Markers of Acute Kidney Injury.
    Joannidis M; Forni LG; Haase M; Koyner J; Shi J; Kashani K; Chawla LS; Kellum JA;
    Crit Care Med; 2019 Oct; 47(10):e820-e826. PubMed ID: 31343478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of urinary biomarkers to predict acute kidney injury in children after liver transplant.
    Fuhrman DY; Kellum JA; Joyce EL; Miyashita Y; Mazariegos GV; Ganoza A; Squires JE
    Pediatr Transplant; 2020 Feb; 24(1):e13608. PubMed ID: 31652022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial.
    Meersch M; Schmidt C; Hoffmeier A; Van Aken H; Wempe C; Gerss J; Zarbock A
    Intensive Care Med; 2017 Nov; 43(11):1551-1561. PubMed ID: 28110412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.